3 Must Own Biotech Stocks For February
The biotech sector has been in an official bear market for some time and is down some 30% since its recent peak in mid-summer. Bargains abound for patient long-term investors.
from Biotech News
The biotech sector has been in an official bear market for some time and is down some 30% since its recent peak in mid-summer. Bargains abound for patient long-term investors.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments